Nurse Practitioner, Adult Health · New York, NY
NPI
1760811640
Since 2013
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
301 E. 17th St. 550
New York, NY, 10003
Phone (212) 263-1260
Groups this clinician bills Medicare through
Medicare paid, 2024
$8,588
177 services
Medicare patients, 2024
82
Average age 71
Drug cost, 2024
$29.4M
3,395 prescriptions
Company payments, 2025
$89.99
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Frank Cefali was code 36415 (venipuncture blood collection), 80 times for 66 patients. In total Frank Cefali billed 177 services in 7 codes, and Medicare paid $8,588.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 80 | 66 | $8.65 | $692 |
| 99215 Office E&M - Established | Office | 53 | 43 | $129.31 | $6,853 |
| 94618 Pulmonary Function Testing | Office | 36 | 31 | $15.45 | $556 |
By year: 2022 $3,097 for 51 services; 2023 $5,923 for 99 services; 2024 $8,588 for 177 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 80 | 66 | $8.65 | $692 |
Medicare prescription drug claims, 2024
In 2024, the drug Frank Cefali prescribed most often to Medicare patients was Opsumit (Macitentan), with 679 prescriptions and refills. In total Frank Cefali wrote 3,395 Medicare prescriptions that cost $29.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Opsumit Macitentan | 679 | 679 | 88 | $8.5M |
| Adempas Riociguat | 584 | 584 | 67 | $8.0M |
| Tadalafil Generic | 537 | 548 | 74 | $562K |
| Ambrisentan Generic | 251 | 257 | 27 | $1.1M |
| Uptravi Selexipag | 222 | 222 | 36 | $5.0M |
| Orenitram Er Treprostinil Diolamine | 193 | 193 | 11 | $2.2M |
| Letairis Ambrisentan | 111 | 111 | 16 | $1.4M |
| Adcirca Tadalafil | 97 | 97 | 14 | $357K |
| Furosemide Generic | 93 | 252 | 39 | $556 |
| Tyvaso Dpi Treprostinil | 86 | 86 | 14 | $2.0M |
| Sildenafil Citrate Generic | 74 | 78 | 15 | $13K |
| Potassium Chloride Generic | 35 | 84 | 21 | $1,215 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 35 | 45 | Under 11 | $1,256 |
| Azelastine Hcl Generic | 27 | 51 | 13 | $931 |
| Eliquis Apixaban | 26 | 60 | Under 11 | $33K |
Brand drugs: 2,108 claims; generic drugs: 1,287 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Frank Cefali $89.99 ($89.99 in general payments such as food, travel and fees) from 1 company. The largest payer was Actelion Pharmaceuticals US, Inc. with $89.99.
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. JNJ | 1 | $89.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.